JP2024521618A5 - - Google Patents
Info
- Publication number
- JP2024521618A5 JP2024521618A5 JP2023564563A JP2023564563A JP2024521618A5 JP 2024521618 A5 JP2024521618 A5 JP 2024521618A5 JP 2023564563 A JP2023564563 A JP 2023564563A JP 2023564563 A JP2023564563 A JP 2023564563A JP 2024521618 A5 JP2024521618 A5 JP 2024521618A5
- Authority
- JP
- Japan
- Prior art keywords
- heptan
- azaspiro
- methanone
- triazole
- cyclopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21170090 | 2021-04-23 | ||
| EP21170090.1 | 2021-04-23 | ||
| CN2022083125 | 2022-03-25 | ||
| CNPCT/CN2022/083125 | 2022-03-25 | ||
| PCT/EP2022/060644 WO2022223750A1 (en) | 2021-04-23 | 2022-04-22 | Heterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521618A JP2024521618A (ja) | 2024-06-04 |
| JP2024521618A5 true JP2024521618A5 (enExample) | 2025-04-22 |
Family
ID=81750728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564563A Pending JP2024521618A (ja) | 2021-04-23 | 2022-04-22 | 複素環式化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240199587A1 (enExample) |
| EP (1) | EP4326714A1 (enExample) |
| JP (1) | JP2024521618A (enExample) |
| KR (1) | KR20240000574A (enExample) |
| CN (1) | CN117295726A (enExample) |
| AR (1) | AR125401A1 (enExample) |
| AU (1) | AU2022260537A1 (enExample) |
| CA (1) | CA3215260A1 (enExample) |
| CL (1) | CL2023003154A1 (enExample) |
| CO (1) | CO2023014721A2 (enExample) |
| CR (1) | CR20230496A (enExample) |
| IL (1) | IL306126A (enExample) |
| MX (1) | MX2023012477A (enExample) |
| PE (1) | PE20240239A1 (enExample) |
| TW (1) | TW202309010A (enExample) |
| WO (1) | WO2022223750A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019322538B2 (en) | 2018-08-13 | 2021-09-30 | F. Hoffmann-La Roche Ag | New heterocyclic compounds as monoacylglycerol lipase inhibitors |
| PL3883936T3 (pl) | 2018-11-22 | 2023-11-20 | F. Hoffmann-La Roche Ag | Nowe związki heterocykliczne |
| US20250170101A1 (en) * | 2021-12-29 | 2025-05-29 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of pain and related conditions |
| WO2023130043A1 (en) * | 2021-12-29 | 2023-07-06 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment of anxiety |
| IL313987A (en) * | 2021-12-29 | 2024-08-01 | Psy Therapeutics Inc | Inhibiting monoacylglycerol lipase (magl) |
| JP2025504522A (ja) * | 2022-01-25 | 2025-02-12 | エフ． ホフマン－ラ ロシュ アーゲー | 新規の複素環式化合物 |
| JP2025525350A (ja) * | 2022-06-24 | 2025-08-05 | エフ． ホフマン－ラ ロシュ アーゲー | Ｍａｇｌ阻害剤としての新規複素環－カルボニル－環式化合物 |
| KR20250060956A (ko) | 2022-08-05 | 2025-05-07 | 컴쿼트 바이오사이언시즈 인크. | 헤테로환 화합물 및 이의 용도 |
| WO2024215863A2 (en) * | 2023-04-13 | 2024-10-17 | Psy Therapeutics, Inc. | Inhibiting monoacylglycerol lipase (magl) |
| WO2025010394A2 (en) * | 2023-07-06 | 2025-01-09 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment and management of inflammatory conditions |
| WO2025010392A2 (en) * | 2023-07-06 | 2025-01-09 | Psy Therapeutics, Inc. | Monoacylglycerol lipase inhibitors and use thereof for the treatment of neurological disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20171057A1 (es) * | 2014-10-08 | 2017-07-21 | Hoffmann La Roche | Derivados espirodiamina como inhibidores de la aldosterona sintasa |
| EP4074378A1 (en) * | 2015-07-02 | 2022-10-19 | Janssen Sciences Ireland Unlimited Company | Antibacterial compounds |
| JP7368357B2 (ja) * | 2017-09-05 | 2023-10-24 | ブラックソーン セラピューティクス インコーポレイテッド | バソプレシン受容体アンタゴニストならびにそれに関連する生成物および方法 |
| CA3129516A1 (en) * | 2018-02-28 | 2019-09-06 | The Trustees Of The University Of Pennsylvania | Low affinity poly(ad-ribose) polymerase 1 dependent cytotoxic agents |
| WO2019209962A1 (en) * | 2018-04-25 | 2019-10-31 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| PL3883936T3 (pl) * | 2018-11-22 | 2023-11-20 | F. Hoffmann-La Roche Ag | Nowe związki heterocykliczne |
| CN111793064B (zh) * | 2019-04-02 | 2023-06-23 | 上海美悦生物科技发展有限公司 | 一种作为irak抑制剂的化合物及其制备方法和用途 |
| IL301492A (en) * | 2020-09-22 | 2023-05-01 | Janssen Pharmaceutica Nv | Cyclobutyl amide monoacylglycerol lipase modulators |
-
2022
- 2022-04-22 KR KR1020237040339A patent/KR20240000574A/ko active Pending
- 2022-04-22 AR ARP220101039A patent/AR125401A1/es unknown
- 2022-04-22 CR CR20230496A patent/CR20230496A/es unknown
- 2022-04-22 EP EP22724696.4A patent/EP4326714A1/en active Pending
- 2022-04-22 JP JP2023564563A patent/JP2024521618A/ja active Pending
- 2022-04-22 AU AU2022260537A patent/AU2022260537A1/en active Pending
- 2022-04-22 WO PCT/EP2022/060644 patent/WO2022223750A1/en not_active Ceased
- 2022-04-22 PE PE2023002921A patent/PE20240239A1/es unknown
- 2022-04-22 TW TW111115346A patent/TW202309010A/zh unknown
- 2022-04-22 CA CA3215260A patent/CA3215260A1/en active Pending
- 2022-04-22 MX MX2023012477A patent/MX2023012477A/es unknown
- 2022-04-22 IL IL306126A patent/IL306126A/en unknown
- 2022-04-22 CN CN202280030020.6A patent/CN117295726A/zh active Pending
-
2023
- 2023-10-20 US US18/490,967 patent/US20240199587A1/en active Pending
- 2023-10-20 CL CL2023003154A patent/CL2023003154A1/es unknown
- 2023-10-30 CO CONC2023/0014721A patent/CO2023014721A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL306126A (en) | Heterocyclic compounds | |
| JP2021502356A5 (enExample) | ||
| JP7791196B2 (ja) | キナーゼ阻害剤としてのインダゾール化合物 | |
| JP2023506642A5 (enExample) | ||
| JP6642942B2 (ja) | セリン／トレオニンキナーゼ阻害剤 | |
| JP2012525349A5 (enExample) | ||
| JP2017500364A5 (enExample) | ||
| JP2014531465A5 (enExample) | ||
| JP2019523233A5 (enExample) | ||
| JP2010510319A5 (enExample) | ||
| JP2019519484A5 (enExample) | ||
| JP2011503166A5 (enExample) | ||
| RU2014139601A (ru) | Ингибиторы серин/треониновых киназ | |
| JP2020529433A5 (enExample) | ||
| JP2010502615A5 (enExample) | ||
| CA2642922A1 (en) | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | |
| JP2016500073A5 (enExample) | ||
| AU2018201953A1 (en) | Certain amino-pyridazines, compositions thereof, and methods of their use | |
| JP2014518214A5 (enExample) | ||
| JP2017502049A5 (enExample) | ||
| JP2015522002A5 (enExample) | ||
| FI3768684T3 (fi) | Oksatsiinimonoasyyliglyserolilipaasin (magl) estäjiä | |
| JP2013523884A5 (enExample) | ||
| RU2016124178A (ru) | Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет | |
| JP2015528022A5 (enExample) |